ReveraGen BioPharma (United States)
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024.
Open Access statistics for ReveraGen BioPharma (United States), United States, covering academic research published from 2012 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
51
Total Open
Publications
36
Total
Citations
1.3K
Open Access
Percentage
71%
Total
Publications
51
Total Open
Publications
36
Total
Citations
1.3K
Breakdown
Publisher Open
12%
Both
45%
Other Platform Open
14%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 41%
12
Hybrid 21%
6
No Guarantees 38%
11
Other Platform Open
Domain 87%
26
Institution 27%
8
Other Internet 23%
7
Preprint 0%
0
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 26 |
Europe PMC | Domain | 4 |
DOI | Other Internet | 4 |
Unknown Repository | Other Internet | 3 |
University of Padua - Padua Research Archive | Institution | 2 |
University of Melbourne - Minerva Access | Institution | 2 |
universiteitleiden.nl OAI-PMH Repository | Institution | 1 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 1 |
ncl.ac.uk OAI-PMH Repository | Institution | 1 |
KU Leuven - Lirias | Institution | 1 |